Thomas Kieber‐Emmons Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

Last publication 2025 Last refreshed 2026-05-16

faculty

42 h-index 243 pubs 5,580 cited

Biography and Research Information

Metrics

  • h-index: 42
  • Publications: 243
  • Citations: 5,580

Selected Publications

  • When Reassurance Falls Short: Rethinking Vaccine Risk Communication (2025)
    1 citation DOI OpenAlex
  • Abstract PO5-02-05: Assessing Vaccine-Mediated Cellular Immune Responses in Patients Receiving Combined Vaccine and Chemotherapy Treatment (2024)
  • Abstract 3860: Characterizing peripheral immune correlates of tumor response in breast cancer patients immunized with the P10s-PADRE vaccine (2024)
  • Abstract 700: Induction of cancer-specific T-cell responses in patients immunized with P10s-PADRE vaccine (2023)
  • Thoughts on mRNA Vaccine Response (2023)
  • VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen (2023)
    3 citations DOI OpenAlex
  • Living with Endemic COVID-19 (2022)
    1 citation DOI OpenAlex
  • Abstract P2-14-15: Timing of the immunization defines immune signature of a peptide cancer vaccine combined with Neoadjuvant chemotherapy in HR+ breast cancer patients (2022)
  • Cancer Patients and COVID-19 Vaccination (2021)
  • P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses (2021)
    10 citations DOI OpenAlex
  • Expert Panel Discussion on Antigenic Sin (2021)
    3 citations DOI OpenAlex
  • Antibodies are the Forefront of Today's Medicine (2021)
  • Antibodies in the Thick of Things (2021)
  • “Why Not Hybridomas” (2021)

View all publications on OpenAlex →